{"date":"2025-03-28","count":28,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-7784-2025-03-28-2147-1pb8ufa","company_id":"7784","company":"安邦生技*","market":"興櫃","industry":"生技醫療","date":"2025-03-28","time":"21:47:38","subject":"公告本公司董事會決議召開114年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安邦生技*（7784），2025-03-28 21:47，「公告本公司董事會決議召開114年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7784-2025-03-28-2143-1hku5w3","company_id":"7784","company":"安邦生技*","market":"興櫃","industry":"生技醫療","date":"2025-03-28","time":"21:43:34","subject":"公告本公司董事會通過113年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安邦生技*（7784），2025-03-28 21:43，「公告本公司董事會通過113年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7784-2025-03-28-2142-bwopfv","company_id":"7784","company":"安邦生技*","market":"興櫃","industry":"生技醫療","date":"2025-03-28","time":"21:42:41","subject":"公告本公司董事會決議不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安邦生技*（7784），2025-03-28 21:42，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6586-2025-03-28-2011-1o92d4l","company_id":"6586","company":"醣基","market":"興櫃","industry":"生技醫療","date":"2025-03-28","time":"20:11:32","subject":"本公司研發之預防性細菌性疫苗(簡稱:CHO-V08)獲台灣衛福部食藥署(TFDA)核准進行一期人體臨床試驗","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：醣基（6586），2025-03-28 20:11，「本公司研發之預防性細菌性疫苗(簡稱:CHO-V08)獲台灣衛福部食藥署(TFDA)核准進行一期人體臨床試驗」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6848-2025-03-28-1831-yc1tdx","company_id":"6848","company":"拉法醫","market":"興櫃","industry":"生技醫療","date":"2025-03-28","time":"18:31:02","subject":"公告本公司董事會決議通過盈餘轉增資發行新股","clause":"第9款","fact_date":"2025-03-28","cite_as":"公開資訊觀測站重大訊息：拉法醫（6848），2025-03-28 18:31，「公告本公司董事會決議通過盈餘轉增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6659-2025-03-28-1747-tvxd02","company_id":"6659","company":"天明製藥","market":"興櫃","industry":"生技醫療","date":"2025-03-28","time":"17:47:31","subject":"董事會決議股利分派。","clause":"第9款","fact_date":"2025-03-28","cite_as":"公開資訊觀測站重大訊息：天明製藥（6659），2025-03-28 17:47，「董事會決議股利分派。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7607-2025-03-28-1747-ub84r7","company_id":"7607","company":"通用幹細胞*","market":"興櫃","industry":"生技醫療","date":"2025-03-28","time":"17:47:14","subject":"公告本公司114年第一次股東臨時會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：通用幹細胞*（7607），2025-03-28 17:47，「公告本公司114年第一次股東臨時會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6576-2025-03-28-1737-1n55qbg","company_id":"6576","company":"逸達","market":"上櫃","industry":"生技醫療","date":"2025-03-28","time":"17:37:10","subject":"前列腺癌新劑型新藥 CAMCEVI 3個月劑型上市許可申請（MAA）獲歐洲藥品管理局（EMA）受理正式進入審理流程","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：逸達（6576），2025-03-28 17:37，「前列腺癌新劑型新藥 CAMCEVI 3個月劑型上市許可申請（MAA）獲歐洲藥品管理局（EMA）受理正式進入審理流程」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6662-2025-03-28-1703-a9yhqf","company_id":"6662","company":"樂斯科","market":"上櫃","industry":"生技醫療","date":"2025-03-28","time":"17:03:30","subject":"本公司董事會決議召開114年股東常會相關事宜(新增討論事項及選舉事項)","clause":"第17款","fact_date":"2025-03-28","cite_as":"公開資訊觀測站重大訊息：樂斯科（6662），2025-03-28 17:03，「本公司董事會決議召開114年股東常會相關事宜(新增討論事項及選舉事項)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6848-2025-03-28-1701-ldk656","company_id":"6848","company":"拉法醫","market":"興櫃","industry":"生技醫療","date":"2025-03-28","time":"17:01:30","subject":"公告本公司董事會決議113年下半年度股利分派","clause":"第31款","fact_date":"2025-03-28","cite_as":"公開資訊觀測站重大訊息：拉法醫（6848），2025-03-28 17:01，「公告本公司董事會決議113年下半年度股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6848-2025-03-28-1701-1lu10v6","company_id":"6848","company":"拉法醫","market":"興櫃","industry":"生技醫療","date":"2025-03-28","time":"17:01:09","subject":"公告本公司董事會決議112年度員工酬勞及董事酬勞分派案","clause":"第44款","fact_date":"2025-03-28","cite_as":"公開資訊觀測站重大訊息：拉法醫（6848），2025-03-28 17:01，「公告本公司董事會決議112年度員工酬勞及董事酬勞分派案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6848-2025-03-28-1700-1dmdgdo","company_id":"6848","company":"拉法醫","market":"興櫃","industry":"生技醫療","date":"2025-03-28","time":"17:00:46","subject":"公告本公司董事會通過113年度財務報告","clause":"第43款","fact_date":"2025-03-28","cite_as":"公開資訊觀測站重大訊息：拉法醫（6848），2025-03-28 17:00，「公告本公司董事會通過113年度財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6848-2025-03-28-1700-tulf6t","company_id":"6848","company":"拉法醫","market":"興櫃","industry":"生技醫療","date":"2025-03-28","time":"17:00:16","subject":"公告本公司董事會決議召開114年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：拉法醫（6848），2025-03-28 17:00，「公告本公司董事會決議召開114年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2025-03-28-1627-1y4ml6x","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2025-03-28","time":"16:27:31","subject":"本公司董事會通過子公司LAUNXP INTERNATIONAL CO., LTD.擬與冠科美博簽署新藥專屬授權合約取得無形資產","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2025-03-28 16:27，「本公司董事會通過子公司LAUNXP INTERNATIONAL CO., LTD.擬與冠科美博簽署新藥專屬授權合約取得無」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2025-03-28-1623-n394ll","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2025-03-28","time":"16:23:33","subject":"代子公司LAUNXP INTERNATIONAL CO., LTD.公告指派董事","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2025-03-28 16:23，「代子公司LAUNXP INTERNATIONAL CO., LTD.公告指派董事」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2025-03-28-1622-1rpjgd9","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2025-03-28","time":"16:22:00","subject":"公告本公司董事會之議決事項，未經審計委員會通過，而經全體董事三分之二以上同意通過者","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2025-03-28 16:22，「公告本公司董事會之議決事項，未經審計委員會通過，而經全體董事三分之二以上同意通過者」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2025-03-28-1620-7fsrt6","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2025-03-28","time":"16:20:19","subject":"本公司董事會決議通過子公司Launxp InternationalCo., Ltd.擬與冠科美博公司(Apollomics Inc.)簽訂亞洲區(不含中國大陸、香港及澳門)APL-101藥物專屬授權合約","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2025-03-28 16:20，「本公司董事會決議通過子公司Launxp InternationalCo., Ltd.擬與冠科美博公司(Apollomic」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6814-2025-03-28-1610-1pzjlpi","company_id":"6814","company":"路迦生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-28","time":"16:10:03","subject":"公告本公司預估未來三個月現金收支情形及銀行可使用融資額度情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：路迦生醫（6814），2025-03-28 16:10，「公告本公司預估未來三個月現金收支情形及銀行可使用融資額度情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6827-2025-03-28-1607-3q8ykn","company_id":"6827","company":"巨生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-28","time":"16:07:19","subject":"公告本公司因配合會計師事務所內部職務調整更換簽證會計師","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：巨生醫（6827），2025-03-28 16:07，「公告本公司因配合會計師事務所內部職務調整更換簽證會計師」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6827-2025-03-28-1602-6r49ey","company_id":"6827","company":"巨生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-28","time":"16:02:16","subject":"公告本公司董事會決議虧損撥補案暨不發放股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：巨生醫（6827），2025-03-28 16:02，「公告本公司董事會決議虧損撥補案暨不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6827-2025-03-28-1553-xvke1e","company_id":"6827","company":"巨生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-28","time":"15:53:35","subject":"公告本公司董事會決議召開114年股東會常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：巨生醫（6827），2025-03-28 15:53，「公告本公司董事會決議召開114年股東會常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6827-2025-03-28-1551-kmy10s","company_id":"6827","company":"巨生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-28","time":"15:51:28","subject":"公告本公司董事會通過113年度個別財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：巨生醫（6827），2025-03-28 15:51，「公告本公司董事會通過113年度個別財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4186-2025-03-28-1509-bwopfv","company_id":"4186","company":"尖端醫","market":"興櫃","industry":"生技醫療","date":"2025-03-28","time":"15:09:04","subject":"公告本公司董事會決議不分派股利","clause":"第31款","fact_date":"2025-03-28","cite_as":"公開資訊觀測站重大訊息：尖端醫（4186），2025-03-28 15:09，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4186-2025-03-28-1505-1o5u6fo","company_id":"4186","company":"尖端醫","market":"興櫃","industry":"生技醫療","date":"2025-03-28","time":"15:05:19","subject":"公告本公司董事會決議補行委任第五屆薪資報酬委員會委員","clause":"第6款","fact_date":"2025-03-28","cite_as":"公開資訊觀測站重大訊息：尖端醫（4186），2025-03-28 15:05，「公告本公司董事會決議補行委任第五屆薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4186-2025-03-28-1504-1dmdgdo","company_id":"4186","company":"尖端醫","market":"興櫃","industry":"生技醫療","date":"2025-03-28","time":"15:04:26","subject":"公告本公司董事會通過113年度財務報告","clause":"第43款","fact_date":"2025-03-28","cite_as":"公開資訊觀測站重大訊息：尖端醫（4186），2025-03-28 15:04，「公告本公司董事會通過113年度財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4186-2025-03-28-1503-1g7c29d","company_id":"4186","company":"尖端醫","market":"興櫃","industry":"生技醫療","date":"2025-03-28","time":"15:03:52","subject":"公告本公司董事會決議召開114年股東常會事宜","clause":"第32款","fact_date":"2025-03-28","cite_as":"公開資訊觀測站重大訊息：尖端醫（4186），2025-03-28 15:03，「公告本公司董事會決議召開114年股東常會事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6660-2025-03-28-1429-52wg6n","company_id":"6660","company":"厚美德","market":"興櫃","industry":"生技醫療","date":"2025-03-28","time":"14:29:38","subject":"公告本公司董事會決議通過設置薪資報酬委員會及委任第一屆薪酬委員","clause":"第9款","fact_date":"2025-03-28","cite_as":"公開資訊觀測站重大訊息：厚美德（6660），2025-03-28 14:29，「公告本公司董事會決議通過設置薪資報酬委員會及委任第一屆薪酬委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6543-2025-03-28-0811-k8dudv","company_id":"6543","company":"普惠醫工","market":"興櫃","industry":"生技醫療","date":"2025-03-28","time":"08:11:24","subject":"公告本公司訂定一一三年下半年度現金股利分派暨除息基準日相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：普惠醫工（6543），2025-03-28 08:11，「公告本公司訂定一一三年下半年度現金股利分派暨除息基準日相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}